Want to join the conversation?
$JNJ has a multitude of promising potential line extensions across every therapeutic area, approx. 40 in total, by 2019. Of this, 10 have more than $0.5Bil potential. Cumulatively, the line extensions for Xarelto and Invokana have the potential to drive $3-5Bil in incremental sales for the cardiovascular franchise.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.